Not knocking AVXL but combining a drug that will help synergistically another drug that doesn't help all that much to start with wouldn't be as big a blockbuster as bryostatin. Is it more likely to get approved?..Maybe and that would be huge but the potential of actually reversing and not simply slowing down memory loss is more likely with this stock IMO. I like both stocks but the science here is potentially groundbreaking and outside the box. JMHO
Market Data 
Markets 
AI
